Aspira Women’s Health (NYSE:AWH) Coverage Initiated at assumed coverage on shares of Aspira Women’s Health (NYSE:AWHGet Rating) in a research report issued to clients and investors on Tuesday. The brokerage set a “sell” rating on the stock.

Aspira Women’s Health Trading Up 1.9 %

Shares of NYSE AWH opened at $0.58 on Tuesday. The company has a market capitalization of $72.39 million, a PE ratio of -2.15 and a beta of 2.89. Aspira Women’s Health has a fifty-two week low of $0.29 and a fifty-two week high of $1.29. The company’s 50-day moving average is $0.42.

Aspira Women’s Health (NYSE:AWHGet Rating) last posted its quarterly earnings results on Thursday, November 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.03. The company had revenue of $2.07 million during the quarter, compared to analysts’ expectations of $2.40 million.

About Aspira Women’s Health

(Get Rating)

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Recommended Stories

Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with's FREE daily email newsletter.